GeneralConnection.com ➔ Dictionary
Dictionary Search

haemophilia b

Synonyms

Noun

1. hemophilia B

2. haemophilia B, Christmas disease, hemophilia, haemophilia, bleeder's disease

Usage
How durable is gene therapy for haemophilia B? - Nature
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
Explainer 2025 Why Is Hemophilia B Called Christmas Disease - Global Biotechnology Company
EAHAD 2026: Nine-Year Outcomes of Gene Therapy - EMJ
Gene therapy can help reduce joint bleeds in hemophilia B: New data - Hemophilia News Today
Single-Dose Gene Therapy Shows Promising Safety, Efficacy, and Patient-Reported Outcomes in Hemophilia B - Docwire News
First subject dosed in Be Biopharma’s trial of haemophilia B therapy - Clinical Trials Arena
Building safeguards for gene therapy in haemophilia - The Lancet
Hemophilia B gene therapy demonstrates long-term success - St. Jude Children's Research Hospital
Exploring gene editing as a potential therapeutic strategy for hemophilia - Frontiers
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
First German haemophilia B patient receives gene therapy HEMGENIX - PharmaTimes
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
New gene therapy reduces bleeding rates for hemophilia B patients - Hemophilia News Today
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B - The New England Journal of Medicine
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
Hemophilia B gene therapy benefits last more than a decade: Study - Hemophilia News Today
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
First-in-human trial of hemophilia B treatment BE-101 starts dosing - Hemophilia News Today
(marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Haemophilia treatment guide: What every patient must know - TheHealthSite
Digital tool could help people with hemophilia ‘live their normal life’ - Hemophilia News Today
Patient in Germany gets hemophilia B gene therapy Hemgenix - Hemophilia News Today
Haemophilia A vs B: Which is more severe? Here’s what sets them apart - TheHealthSite
Five-year study confirms durable efficacy of etranacogene dezaparvovec - PharmaTimes
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties - Nature
ASH: CSL proves efficacy of hemophilia B gene therapy Hemgenix holds up after 5 years - Fierce Pharma
NICE recommends weekly injection for severe haemophilia B - The Pharmaceutical Journal
Eloctate, Alprolix control bleeds in hemophilia patients’ major surgeries - Hemophilia News Today
First NHS patient treated with CSL Behring’s haemophilia B gene therapy Hemgenix - PMLiVE
Haemophilia gene therapy patients thriving over a decade after treatment | UCL News - UCL - UCL | University College London
Hull teenager first to be treated with new haemophilia drug - BBC
Hemophilia B Gene Therapy Shows Promise as Long-Term Treatment - Docwire News
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors - PR Newswire
CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B - Yahoo Finance
Hemophilia gene therapy: A new era of treatment and the obstacles ahead - Drug Discovery News
Hemophilia B Pipeline 2026 Report Highlights Next-Gen Gene Therapies, FDA Advances, and Clinical Momentum Across Novo Nordisk, Pfizer, Sanofi & Emerging Biotechs | DelveInsight - Barchart
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations - Managed Healthcare Executive
One dose of gene therapy gives years of relief from blood disorder - Nature
Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients - PMLiVE
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study - The New England Journal of Medicine
China Explores Weight-Based Pricing for First Domestic Hemophilia B Gene Therapy - NAVLIN DAILY
Spotlight on the ISTH Hemophilia Treatment Guidelines and Alternate Recommendations - Hematology Advisor
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B - PharmTech.com
Extended hemophilia half-life products aid care, but raise costs - Hemophilia News Today
Novo Nordisk’s Alhemo approved by FDA for expanded haemophilia use - PMLiVE
Systemic lupus erythematosus caused acquired hemophilia B without evidence of factor IX inhibitors - Wiley Online Library
Hemophilia B Market: Rapid Increment Driven by Innovation - openPR.com
G-BA Rates “Considerable” Added Benefit of Alhemo for Hemophilia B Patients - NAVLIN DAILY
How Fitusiran Changes the Treatment Landscape in Hemophilia: Guy Young, MD - The American Journal of Managed Care® (AJMC®)
Expanding Alhemo to hemophilia without inhibitors recommended - Hemophilia News Today
Pfizer reports positive results from Phase III BASIS trial for haemophilia - Clinical Trials Arena
FDA Expands Approval of Concizumab-mtci to Include Hemophilia A, B Without Inhibitor Use - Pharmacy Times
Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors - BioSpace
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
European regulatory authority adopts positive opinion for Novo Nordisk’s Alhemo® (concizumab), recommending label expansion to treat haemophilia A and B without inhibitors - Yahoo Finance
FDA expands approvals for Novartis lipid drug, Novo haemophilia prophylatic - FirstWord Pharma
Switching to Extended Half-Life Therapies Improves Hemophilia Care, but Raises Short-Term Costs - Managed Healthcare Executive
Concizumab approved to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors - GOV.UK
Why Hympavzi Secured English Funding For Hemophilia B But Not Hemophilia A - Citeline News & Insights
NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS - Pharmafile
CSL’s haemophilia therapy shows durable five-year benefits in landmark trial results - Biotech Dispatch
Assessing stigma in a predominantly male hemophilia population: a Chinese cross-sectional study - Frontiers
The National “New Methods” Decision Forum in Norway recommends CSL’s gene therapy HEMGENIX® for adults with severe or moderately severe haemophilia B without a history of Factor IX inhibitors - Mynewsdesk
First NHS patient given world's most expensive drug that costs £2.6 million per dose - LADbible
How pioneering gene therapy changed the life of the first man in Wales to receive it - Nation.Cymru
Pfizer says patient dies after receiving hemophilia drug in trial - ETPharma.com
Pfizer's weekly haemophilia drug backed for NHS use - pharmaphorum
Non-replacement therapy for people with haemophilia B: another step towards health equity - The Lancet
First gene therapy to treat haemophilia B - European Medicines Agency (EMA)
CDC Hemophilia Mutation Projects (CHAMP and CHBMP) - Centers for Disease Control and Prevention | CDC (.gov)
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - The New England Journal of Medicine
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B - The New England Journal of Medicine
A Reality Check of Hemophilia Care: What a Real-World Study Says About the Unmet Needs of People With Hemophilia A or B - Managed Healthcare Executive
Six biotech companies leading the charge in hemophilia treatment - Labiotech.eu
With hemophilia B, a lifetime of worry eased with one infusion - Penn Today
Man battling disease since he was a baby incredibly no longer needs weekly treatment - Wales Online
Successful management with regular factor IX replacement during pregnancy in a hemophilia B carrier: A case report - Wiley
First subcutaneous treatment for severe Haemophilia B recommended - National Health Executive
First hemophilia B patients in Denmark treated with Hemgenix –... - Hemophilia News Today
First patient in Wales receives ground-breaking gene therapy treatment - Nation.Cymru
NMPA approves BBM and Takeda China’s haemophilia B therapy - Pharmaceutical Technology
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system - Nature
Breaking ground in haemophilia B gene therapy: insights from the HOPE-B trial and beyond - The Lancet
UK Approves Marstacimab for Severe Haemophilia A or B - Medscape
Transformational therapy cures haemophilia B - BBC
Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China - The Manila Times
Belief, Takeda’s home-grown haemophilia B gene therapy gains nod in China - FirstWord Pharma
Real Stories from People Living with Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
Novo Nordisk’s Alhemo Recommended for Expanded Use in Europe for Haemophilia A and B - Insider Monkey
CSL Behring treats two patients with gene therapy for haemophilia B - Clinical Trials Arena
World Haemophilia Day: Over 5,000 Kenyans living with blood disorder - KBC Digital News
CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice - Nature
Haemophilia - The Lancet
From Bleeds To Prevention, India’s Haemophilia Care Is At A Turning Point | World Haemophilia Day Special - ETV Bharat
Hemophilia B Gene Therapy Produces Durable Response for 90% of Participants - The American Journal of Managed Care® (AJMC®)
uniQure announces FDA approval of first gene therapy for adults with hemophilia B - uniqure.gcs-web.com
Researchers welcome $3.5-million haemophilia gene therapy — but questions remain - Nature
Single-dose gene therapy is potentially life-changing for adults with hemophilia B - Penn Medicine
Foreign Language Equivalents
Foreign Language Equivalents of 'haemophilia b'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
haemophiliab ,   haemophiia b,   hae,ophilia b,   haemophilai b,   haempohilia b,   hemophilia b,   haemohilia b,   haemophilis b,   haemophilia ,   haemophiilia b,   haemophiila b,   haemophiliab,   haeemophilia b,   haemophulia b,   haemophi;ia b,   haemophilia b,   hsemophilia b,   haemoophilia b,   haemmophilia b,   haemophiliaa b,   haeophilia b,   gaemophilia b,   haemophilia bb,   haemophila b,   haemophikia b,   haemopholia b,   aemophilia b,   haemopjilia b,   haemopgilia b,   haemopphilia b,   haempphilia b,   hhaemophilia b,   haemiphilia b,   haemopihlia b,   harmophilia b,   haemophilua b,   haenophilia b,   haemoohilia b,   haeomphilia b,   haemopilia b,   haemphilia b,   haemophlia b,   haemophiloa b,   haemophillia b,   haaemophilia b,   heamophilia b,   jaemophilia b,   hamophilia b,   haemophhilia b,   haemophilia n,   haemo[hilia b,   haemophili b,   haemohpilia b,   ahemophilia b,   hawmophilia b,   hameophilia b,   haemophliia b,   haemophiliia b,   haemophilia v,   haemophili ab
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z